THC, Δ9-tetrahydrocannabinol, is a neutral cannabinoid, well known for being strongly psychoactive. Of all the scientific discoveries that have been made about THC, the single most important was how THC enabled scientists to discover the existence of the brain’s natural cannabinoid system in vertebrate animals (including humans): a critical part of physiology that, up until then, was unknown. THC has been shown to be effective in the treatment of a variety of ailments and disorders including pain, tumors, nausea and ADHD.
Tetrahydrocannabinolic acid, like other acid cannabinoids, is not psychoactive. THC-A is strongly anti-inflammatory, encourages appetite, is anti-tumor, combats insomnia, and is antispasmodic. THC-A is the most abundant terpenoid (and Cannabinoid) in the vast majority of Cannabis grown in the U.S., reaching levels over 30% of dry weight for flowers from female, unpollinated plants (sensomilla). Many “high THC” strains, when grown and harvested optimally, produce about 15% THC-A by dry weight, though this can vary widely. THCA turns into THC via heat or time.
Cannabinol is an oxidation product of THC. It normally forms when THC is exposed to oxygen and heat. A high level of CBN often reflects cannabis that is old or has been exposed to significant heat. CBN is known to be very slightly psychoactive and more strongly sedative than other known Cannabinoids. As such, samples with significant CBN (approaching 1% by weight) can be useful to treat insomnia. CBN is also somewhat effective as an anti-emetic and anticonvulsant.
Cannabigerol is non psychoactive, and has been shown to stimulate the growth of new brain cells, including in the elderly; it should be noted that genuinely neurogenic compounds are extremely rare. CBG also stimulates bone growth, is antibacterial and anti-tumor, and combats insomnia. CBG has been shown effective in reducing intraocular pressure, and is promising for the treatment of inflammatory bowel diseases, including Crohn’s disease.
Cannabichromene is also non psychoactive, and has been shown to be about ten times more effective than CBD in treating anxiety and stress. It also displays efficiency in treating inflammation, pain relief and is both anti-viral and anti-tumor. CBC has been shown to stimulate the growth of bone tissue.
Cannabidiol is “non-psychoactive” (in that it does not produce the euphoria, time dilation, or anxiety normally produced by THC) and has been shown to be extremely valuable in the treatment of seizure disorders such as Epilepsy and Dravet’s Syndrome. Its lack of psychoactivity makes it ideal in treating children, the elderly and patients that prefer to remain clear headed and focused. CBD is often as effective as THC in the management of pain and tumors. CBD also lowers blood sugar, and has been used in the treatment of Diabetes. CBD has a calming effect, and is useful in the treatment of stress related disorders and sleep loss.
Until recently, Cannabidiolic acid was much more commonly found in higher concentrations in Ruderalis than in Cannabis. In the last few years, strains of Cannabis have been hybridized that produce more CBDA than THCA, including “Cannatonic-C6” and “ACDC.” It appears to have anti-emetic effects as well as anti-proliferative effects, making it ideal for fighting cancer. It also has been shown to be an anti-inflammatory and to possess anti-bacterial properties.